Author

Andres F. Muriel‐Torres

Observed name: Andres Muriel-Torres

Institutions: Massachusetts Eye and Ear Infirmary, Harvard University, University of Rochester

Observed institutions: Massachusetts Eye and Ear Infirmary, Harvard University, University of Rochester

OpenAlex ID: A5114849587

An mRNA-encoded dominant-negative inhibitor of transcription factor RUNX1 suppresses vitreoretinal disease in experimental models

2024 · Michael O’Hare, William P. Miller, et al. · Science Translational Medicine · 12

ApoE3 Christchurch and tau interaction as a protective mechanism against Alzheimer's disease

2025 · Paula Perez‐Corredor, Said Arevalo‐Alquichire, et al. · Alzheimer s & Dementia · 7

Design and Application of a µSiM Outer Blood-Retinal Barrier (OBRB) Model as a Drug Development Tool

2026 · Kevin C. Ling, Jordan Jones, et al. · bioRxiv (Cold Spring Harbor Laboratory)

Development of an antisense oligonucleotide targeting EFEMP1 in models relevant to macular degeneration

2026 · William P. Miller, Said Arevalo-Alquichire, et al. · Molecular Therapy — Nucleic Acids

Works count: 4

Citation count: 19

H-index: 2

I10-index: 1